Migraine clinical trials in Ohio
12 studies for Migraine are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- and 3 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Jun 12, 2026 · NCT05164172BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Recruiting
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05987592Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
RecruitingPhase 4
Ages 6 to 11 · All sexes · Updated Jan 27, 2025 · NCT04748601Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
RecruitingObservational studyHealthy volunteers welcome
Ages 10 to 19 · All sexes · Updated Aug 22, 2024 · NCT05752396From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.